Quality of Life in Ventilator-dependant Neuromuscular Patients

NCT ID: NCT04652401

Last Updated: 2022-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

119 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-02

Study Completion Date

2021-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims at evaluating the quality of life of patients with slowly progressive neuromuscular disorders who are dependant on mechanical ventilation (daily usage ≥ 16h).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Diseases Respiration, Artificial Tracheostomy Noninvasive Ventilation Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with slowly progressive neuromuscular disorder (NMD), non walking
* Patients dependant on mechanical ventilation (daily usage ≥ 16h) for at least 1 year before inclusion
* Aged ≥ 18 yo
* Consent for participation
* Affiliated to a social security regime

Exclusion Criteria

* Patients with medically non-stable NMD: fever, acute respiratory infection, organ decompensation
* Patients with significant cognitive impairment (inability to read and/or incomprehension of questions)
* Patients with fast-evolving neuromuscular disease
* Patients declining to participate in the study
* Patients under guardianship and/or trusteeship
* Pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Garches

OTHER

Sponsor Role collaborator

AFM Téléthon

UNKNOWN

Sponsor Role collaborator

FilNeMus

UNKNOWN

Sponsor Role collaborator

Centre d'Investigation Clinique et Technologique 805

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathieu Delorme, MSc

Role: PRINCIPAL_INVESTIGATOR

Université Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, FRANCE

Frederic Lofaso, MD, PhD

Role: STUDY_DIRECTOR

Université Paris-Saclay, UVSQ, ERPHAN, 78000, Versailles, FRANCE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AFM Téléthon

Évry, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-A00997-32

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.